The transcatheter heart valve replacement market is expected to grow at a compound annual growth rate of 12 percent from 2022 to 2032, according to a new report from consulting firm FMI.
The report pointed to the COVID-19 pandemic as a market growth driver because of increased digitization creating new opportunities in the market. The U.S. is expected to see the most significant growth within the transcatheter heart valve replacement North American market, according to the Aug. 8 report.
The report used historical market research data from 2015 to 2020 to project the transcatheter heart valve replacement market from 2022 to 2032.